RPRX – Royalty Pharma PLC- Cl A
Investors holding4
Combined shares6,822,991
Combined reported value$398.2M
RPRX chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Pat Dorsey | 8.23 | Reduced 1.7% | 2,415,667 | $141.0M | Q3 2026 |
| Samantha McLemore | 6.70 | Reduced 4.9% | 3,422,067 | $199.7M | Q3 2026 |
| Paul Tudor Jones narrow view | 0.14 | Reduced 16.4% | 510,736 | $29.8M | Q3 2026 |
| Ray Dalio narrow view | 0.12 | Added 116.0% | 474,521 | $27.7M | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Samantha McLemore | Reduced 4.9% | 3,422,067 | 0.35 |
| Q3 2026 | Pat Dorsey | Reduced 1.7% | 2,415,667 | 0.14 |
| Q3 2026 | Ray Dalio narrow view | Added 116.0% | 474,521 | 0.06 |
| Q3 2026 | Paul Tudor Jones narrow view | Reduced 16.4% | 510,736 | 0.03 |
| Q2 2026 | Pat Dorsey | Added 7.9% | 2,456,528 | 0.65 |
| Q2 2026 | Samantha McLemore | Reduced 1.2% | 3,598,808 | 0.08 |
| Q2 2026 | Ray Dalio narrow view | New | 219,687 | 0.05 |
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 9.1% | 610,736 | 0.01 |
| Q1 2026 | Samantha McLemore | Added 9.3% | 3,643,716 | 0.55 |
| Q1 2026 | Paul Tudor Jones narrow view | Reduced 27.4% | 671,680 | 0.07 |
| Q1 2026 | Pat Dorsey | Added 0.8% | 2,276,570 | 0.07 |
| Q4 2025 | Samantha McLemore | Added 6.9% | 3,333,675 | 0.32 |
| Q4 2025 | Pat Dorsey | Reduced 3.9% | 2,259,469 | 0.31 |
| Q4 2025 | Paul Tudor Jones narrow view | Added 7.1% | 924,819 | 0.01 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Ray Dalio narrow view | Added 116.0% | 474,521 | 0.06 |
| Q2 2026 | Pat Dorsey | Added 7.9% | 2,456,528 | 0.65 |
| Q2 2026 | Ray Dalio narrow view | New | 219,687 | 0.05 |
| Q1 2026 | Samantha McLemore | Added 9.3% | 3,643,716 | 0.55 |
| Q1 2026 | Pat Dorsey | Added 0.8% | 2,276,570 | 0.07 |
| Q4 2025 | Samantha McLemore | Added 6.9% | 3,333,675 | 0.32 |
| Q4 2025 | Paul Tudor Jones narrow view | Added 7.1% | 924,819 | 0.01 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Samantha McLemore | Reduced 4.9% | 3,422,067 | 0.35 |
| Q3 2026 | Pat Dorsey | Reduced 1.7% | 2,415,667 | 0.14 |
| Q3 2026 | Paul Tudor Jones narrow view | Reduced 16.4% | 510,736 | 0.03 |
| Q2 2026 | Samantha McLemore | Reduced 1.2% | 3,598,808 | 0.08 |
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 9.1% | 610,736 | 0.01 |
| Q1 2026 | Paul Tudor Jones narrow view | Reduced 27.4% | 671,680 | 0.07 |
| Q4 2025 | Pat Dorsey | Reduced 3.9% | 2,259,469 | 0.31 |
History
4 peakQ3 2026: 4 tracked investors
20202026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Pat Dorsey | 2.42M | 2.46M | 2.28M | 2.26M | 2.35M | – | – | – |
| Samantha McLemore | 3.42M | 3.60M | 3.64M | 3.33M | 3.12M | 2.99M | 2.97M | 2.88M |
| Paul Tudor Jones | 510.7K | 610.7K | 671.7K | 924.8K | 863.8K | 642.7K | 727.7K | 735.0K |
| Ray Dalio | 474.5K | 219.7K | – | – | – | – | – | 49.4K |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).